Minimisation of metabolic networks defines a new functional class of genes
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Authors
Abstract
AbstractConstruction of minimal metabolic networks (MMNs) contributes both to our understanding of the origins of metabolism and to the efficiency of biotechnological processes by preventing the diversion of flux away from product formation. We have designed MMNs using a novel in silico synthetic biology pipeline that removes genes encoding enzymes and transporters from genome-scale metabolic models. The resulting minimal gene-set still ensures both viability and high growth rates. The composition of these MMNs has defined a new functional class of genes termed Network Efficiency Determinants (NEDs). These genes, whilst not essential, are very rarely eliminated in constructing an MMN, suggesting that it is difficult for metabolism to be re-routed to obviate the need for such genes. Moreover, the removal of NED genes from an MMN significantly reduces its global efficiency. Bioinformatic analyses of the NED genes have revealed that not only do these genes have more genetic interactions than the bulk of metabolic genes but their protein products also show more protein-protein interactions. In yeast, NED genes are predominantly single-copy and are highly conserved across evolutionarily distant organisms. These features confirm the importance of the NED genes to the metabolic network, including why they are so rarely excluded during minimisation.
Description
Acknowledgements: We thank Charles Boone (Toronto), Balazs Papp (Szeged), Jolanda van Leeuwen (Lausanne), Soukaina Timouma (Manchester), Jonas Warringer (Gothenbug), and Valerie Wood (Cambridge) for helpful discussions. D.D. is supported by the Future Biomanufacturing Research Hub (Future BRH), funded by the Engineering and Physical Sciences Research Council (EPSRC) and Biotechnology and Biological Sciences Research Council (BBSRC) as part of UK Research and Innovation (grant EP/S01778X/1). G.J. was supported by a Biotechnology & Biological Sciences Research Council (UK) grant no. BB/N02348X/1 to SGO as part of the IBiotech Program, and by the Industrial Biotechnology Catalyst (Innovate UK, BBSRC, EPSRC) to support the translation, development and commercialization of innovative industrial biotechnology processes. G.N. and G.J. thank the University of Catania for leave to pay extended research visits to Cambridge.

